SCHEMBL1848865

SCHEMBL1848865

[CH2]C#Cc1ccc2nc(Nc3ccccc3F)ncc2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTK2 Q05397 2/20 0.42
▸ AURKA O14965 4/20 0.39
▸ FGFR1 P11362 3/20 0.37
▸ FGFR4 P22455 2/20 0.37
▸ RAD52 P43351 1/20 0.37
▸ CCNC P24863 1/20 0.37
▸ CDK8 P49336 1/20 0.37
▸ FGFR3 P22607 2/20 0.37
▸ FGFR2 P21802 1/20 0.37
▸ NPC1 O15118 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ MAPK8 P45983 4/20 0.36
▸ MAPK9 P45984 4/20 0.35
▸ MAPK10 P53779 3/20 0.35
▸ SYK P43405 3/20 0.35
▸ CDK2 P24941 2/20 0.35
▸ PLK4 O00444 1/20 0.35
▸ PDPK1 O15530 1/20 0.35
▸ JAK2 O60674 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7791030 0.73 FLT1 (0.55) PTK2AURKAFGFR1FGFR4FGFR3
SCHEMBL1847410 0.72 BRAF (0.51) AURKANPC1RAB9ASMN1; SMN2SYK
SCHEMBL1868898 0.66 BRAF (0.45) PTK2AURKAFGFR1FGFR3MAPK8
SCHEMBL29398215 0.66 PTK2 (0.48) PTK2AURKACCNCCDK8NPC1
SCHEMBL17110620 0.65 POLB (0.56) PTK2AURKARAD52NPC1RAB9A
SCHEMBL7799235 0.64 CSF1R (0.52) AURKAFGFR1FGFR4SMN1; SMN2SYK
SCHEMBL22191517 0.63 PTK2 (0.46) PTK2AURKACCNCCDK8NPC1
SCHEMBL1866091 0.62 RPS6KB1 (0.38) RPS6KB1
SCHEMBL6851890 0.62 NPC1 (0.53) NPC1RAB9ASMN1; SMN2
SCHEMBL3951907 0.62 AURKA (0.56) PTK2AURKACCNCCDK8NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2323986-A2 HETOEROCYCLYL CARBONIC ACID AMIDES AS ANTIPROLIFERATIVE AGENTS, PDKL INHIBITORS Boehringer Ingelheim International GmbH (DE) 2011-05-25 — — EP disclosed
Send feedback